Kizilbük Gayrimenkul Yatirim Ortakligi A.S. (IST:KZBGY)
Turkey · Delayed Price · Currency is TRY 14.19
-0.26 (-1.80%)
Last updated: Aug 13, 2025
CTI BioPharma Revenue
Kizilbük Gayrimenkul Yatirim Ortakligi A.S. had revenue of 612.22M TRY in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 10.47B. In the year 2024, Kizilbük Gayrimenkul Yatirim Ortakligi A.S. had annual revenue of 9.86B.
Revenue (ttm)
10.47B
Revenue Growth
n/a
P/S Ratio
1.60
Revenue / Employee
249.23M
Employees
40
Market Cap
16.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.86B | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition